194 related articles for article (PubMed ID: 21952824)
21. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk.
Xiang B; Mi YY; Li TF; Liu PF
Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123
[TBL] [Abstract][Full Text] [Related]
22. Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.
Dholariya S; Mir R; Zuberi M; Yadav P; Gandhi G; Khurana N; Saxena A; Ray PC
Clin Transl Oncol; 2016 Jan; 18(1):73-81. PubMed ID: 26209050
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
Yan Y; Wu R; Li S; He J
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
[TBL] [Abstract][Full Text] [Related]
24. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
[TBL] [Abstract][Full Text] [Related]
25. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
[TBL] [Abstract][Full Text] [Related]
26. MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.
Wan Y; Wu W; Yin Z; Guan P; Zhou B
BMC Cancer; 2011 May; 11():208. PubMed ID: 21619694
[TBL] [Abstract][Full Text] [Related]
27. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.
Gu Y; Zhou X; Zhang SL
Genet Mol Res; 2011 Oct; 10(4):3609-19. PubMed ID: 22057999
[TBL] [Abstract][Full Text] [Related]
29. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
30. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
31. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.
Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M
Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596
[TBL] [Abstract][Full Text] [Related]
32. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Wang Y; Kringen P; Kristensen GB; Holm R; Baekelandt MM; Olivier M; Skomedal H; Hainaut P; Tropé CG; Abeler VM; Nesland JM; Børresen-Dale AL; Helland A
Hum Mutat; 2004 Jul; 24(1):21-34. PubMed ID: 15221786
[TBL] [Abstract][Full Text] [Related]
33. The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects.
Yang X; Yang B; Liu Y; Xu S; Li B
Indian J Dermatol; 2013 May; 58(3):175-80. PubMed ID: 23723465
[TBL] [Abstract][Full Text] [Related]
34. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis.
Zhang Y; Zhang D; Zhao L; Sun L; Dong Q; Cheng L; Cheng R
Curr Probl Cancer; 2018 Nov; 42(6):582-592. PubMed ID: 30316510
[TBL] [Abstract][Full Text] [Related]
35. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
Zhou X; Gu Y; Zhang SL
Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
[TBL] [Abstract][Full Text] [Related]
36. Association between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis.
Xia LY; Zeng XT; Li C; Leng WD; Fan MW
Asian Pac J Cancer Prev; 2013; 14(10):6127-30. PubMed ID: 24289637
[TBL] [Abstract][Full Text] [Related]
37. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis.
Wang S; Lan X; Tan S; Wang S; Li Y
Tumour Biol; 2013 Oct; 34(5):2511-20. PubMed ID: 23812725
[TBL] [Abstract][Full Text] [Related]
38. Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.
Zhao Y; Wang F; Shan S; Zhao Y; Qiu X; Li X; Jiao F; Wang J; Du Y
Int J Med Sci; 2010 Sep; 7(5):300-8. PubMed ID: 20827430
[TBL] [Abstract][Full Text] [Related]
39. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
